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Abstract The nature of the cytopathic effect exerted by the 
lethal factor toxin (LF) of Bacillus anthracis on sensitive cells is 
unknown. The toxin requires the passage through acidic vesicles 
in order to exert its effect within the cytosol. Here, we show that 
bafilomycins and concanamycin A, selective inhibitors of the 
vacuolar ATPase proton pump, are the most powerful known 
inhibitors of LF macrophage toxicity. These inhibitors are fully 
active long after LF addition to macrophages, uggesting that LF 
enters the cytosol after having reached a late endosomal 
compartment. 
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I. Introduction 
Bacillus anthracis, a Gram-positive bacterium, produces 
three protein toxin components, which are non-toxic if tested 
separately: protective antigen (PA, 83 kDa), edema factor 
(EF, 89 kDa) and lethal factor (LF, 83 kDa) [1]. PA is neces- 
sary for the activity of EF and LF to be displayed inside 
intact cells. EF is a calmodulin-dependent adenylate cyclase 
[2,3], whereas the biochemical mechanism of action of LF 
remains unknown. 
Intoxication of macrophage cell lines by LF starts with PA 
binding to its cellular receptor. PA is then proteolytically 
cleaved by furin or furin-like cell proteases [4,5] and LF binds 
to the receptor bound C-terminal fragment of PA (63 kDa). 
The LF-PA63 complex is internalized by receptor-mediated 
endocytosis and appears to enter the lumen of acidic intracel- 
lular compartments, based on the observation that lysosomo- 
tropic agents prevent the cytotoxic activity of LF on macro- 
phage cell lines [6-9]. Among the different cell types of an 
organism, LF is particularly active towards macrophages [10]. 
Bafilomycins (A1, B1, C and D) and concanamycin A are 
specific inhibitors of the vacuolar ATPase proton pump 
(V-ATPase) [11,12]. This pump is responsible for the lumenal 
acidic pH of several intracellular compartments including 
early and late endosomes and lysosomes [13,14]. These drugs 
inhibit proton flow through the proton channel of the 
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V-ATPase [15] and have been increasingly used to probe the 
role of the V-ATPase in organelle acidification and of intra- 
cellular transmembrane pH gradients in several cell processes 
[13,14,16-19]. Here, we show that concanamycin A and bail- 
lomycins are the most powerful inhibitors of LF cytotoxicity 
and that they are active long after the addition of LF to cells. 
2. Materials and methods 
2.1. Chemicals and reagents 
Concanamycin A, bafilomycins A1, B1, C1 and D were prepared 
and purified as described previously [11,12]. They were dissolved in 
dimethyl sulfoxide at a concentration of 1 mM and stored in aliquots 
at -80°C. Their concentrations were determined as in [11] using the 
respective molar extinction coefficients published by Werner and Ha- 
genmaier [20] for bafilomycin B1 and C1 and by Drrse et al. [12] for 
concanamycin A, bafilomycin A1 and D. [125I]Na nd 1,3,4,6-tetra- 
chloro-3,6-diphenylglycouryl (IODO-GEN) were from Amersham In- 
ternational (Amersham, UK) and from Sigma (St. Louis, MO, USA), 
respectively. 
2.2. Cell culture 
The toxin-sensitive murine macrophage-like c ll lines J774.A1 and 
RAW264.7 were obtained from the American Type Culture Collection 
(ATCC TIB 67, Rockville, MD, USA) and from the European Col- 
lection of Animal Cell Culture (ECAAC 91062702, Salisbury, UK), 
respectively. They are maintained in RPMI 1640 supplemented with 
10% heat-inactivated fetal calf serum, penicillin (200/ag/ml) and strep- 
tomycin (100 ~tg/ml) and kept at 37°C in a 5% CO2 atmosphere. 
2.3. Toxin 
PA and LF were obtained from the culture supernatant fluids of the 
Bacillus anthracis trains RP42 and RP4, respectively [21], and puri- 
fied as described in [22]. Briefly, culture supernatants equilibrated in 
20 mM Tris-HCl, pH 6.5 buffer were loaded onto the Mono-Q HR 
column (Pharmacia, Uppsala, Sweden). Proteins were eluted in the 
same buffer at 1 ml/min and 4°C with a 30 ml NaC1 linear gradient 
(~400 mM). 
LF was radiolabelled with 1251 by the IODO-GEN method accord- 
ing to the procedure of described in [23]; specific activity of [125I]LF 
was 107 cpm/~g. LF cytotoxicity was not affected by this iodination 
procedure. 
2.4. Cell binding and internalization of [1251]LF 
Experiments were performed at 4°C in DMEM pH 7.2 without 
sodium bicarbonate and with 10% fetal calf serum: J774.A1 cells 
were incubated for 1 h without or with concanamycin A (5× 10 -8 
M) or bafilomycin A1 (5x 10 7 M) in the absence or presence of 
PA (500 ng/ml). Cells were then washed with medium and incubation 
was continued for 1 h with [125I]LF (final concentration: 50 ng/ml) 
and inhibitors. Cells were washed again and incubated at 37°C with 
pre-warmed medium in the presence or in the absence of 3 mg/ml 
pronase (Boehringer, Mannheim, Germany). Such a treatment re- 
leases in the medium all cell surface-associated [125I]LF. In the sam- 
ples not containing pronase, it was added after 30 min and incubation 
was prolonged for an additional 30 min. Detached cells were recov- 
ered by centrifugation, and radioactivity in the pellet (internalized LF) 
and in the supernate (cell surface-associated LF) was counted. 
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2.5. Cytotoxicity experiments 
Cytotoxicity of LF was determined with the method described by 
Hansen et al. [24]. Briefly, cells were harvested by scraping with a 
rubber policeman and plated at a density of 5 × 104 cells/well in 96- 
well microtiter plates. When macrophages had reached confluence 
(after 2-3 days), PA (500 ng/ml) and various amounts of LF, LF 
plus inhibitor or inhibitor alone were added, and incubation was 
continued for 4 h. 30 ml of tetrazolium salt (4 mg/ml PBS) were 
then added and after 1.5 h incubation, the reaction was stopped by 
addition of 100 ml of stop buffer (20% w/v SDS, 50% v/v DMF, pH 
4.7). Plates were shaken overnight at room temperature and absorb- 
ance was measured at 534 nm in a multiwell plate reader. 
2.6. Neutral red uptake 
The method previously described by Papini et al. was followed [18]. 
Briefly, cells were plated as described above in 96-well microtiter 
plates. Experiments were carried out with or without the various 
drugs, and then the Neutral red solution (0.05% w/v Neutral red, 
0.3% w/v BSA in PBS) was added to the cells for 5 min at 37°C. Cells 
were then washed three times with PBS, 3% w/v BSA. Neutral red was 
extracted using acidified ethanol (70% ethanol, 0.37% HC1). Readings 
were taken at 534 nm with a microwell plate reader. 
3. Results and discussion 
Previous experiments have shown that LF has to enter an 
intracellular acidic compartment  in order to display its toxic 
activity in the cytosol of macrophages [6-9]. This conclusion 
was derived from the protective ffect exerted by lysosomo- 
tropic agents such as ammonium chloride, monensin and 
chloroquine. The action of these agents is not restricted to 
endosomes and lysosomes, and therefore some of their cellular 
effects may be not directly correlated with neutral ization of 
intracellular acidic compartments.  On the contrary, the 
macrolide antibiotics concanamycin A (conc A) and bafilomy- 
cins A1 (bafA1), B1, C1 and D were characterized as specific 
and powerful inhibitors of the V-ATPase which is responsible 
for acidification of the lumen of endosomal and lysosomal 
compartments.  Fig. 1 shows that these drugs added to the 
macrophage cell line J774A.1 inhibit the cytotoxic activity 
of LF. Overlapping results were obtained with the 
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Fig. 1. Inhibition of the cytopathic effect of LF. J774.A1 cells were 
incubated with the indicated concentrations of concanamycin A 
(©), bafilomycins A1 (I), B1 (D), C1 (11) and D (Or) for 1 h and 
then treated with PA (500 ng/ml) and LF (100 ng/ml) for an addi- 
tional 4 h. Cell death was determined as described in Section 2 and 
expressed as percentage of the LF effect induced in cells not treated 
with inhibitor. Values are the mean of three experiments run in trip- 
licates and bars represent + SE. 
Table 1 
Comparison of bafilomycins and concanamycin A inhibition of an- 
thrax lethal factor cytotoxicity on J774.A1 and RAW264.7 macro- 
phage cell line and of Neurospora crassa V-ATPase 
Inhibitor ICs0 (M) *ICso (gmol/mg) 
J774.A1 RAW264.7 N.c. V-ATPase ~ 
Concanamycin A 2.8x 10 -9 3.4× 10 9 2× 10 -6 
Bafilomycin A1 4.4× 10 -s 3.5×10 .8 5×10 a 
Bafilomycin BI 8.2 × 10 -s 6.6 × 10 -s n.d. 
Bafilomycin C 2.1×10 -7 1.8×10 7 n.d. 
Bafilomycin D 2.7 X 10 -6 n.d. 2 x 10 -3 
~IC56 values were calculated with the fit function of the 'origin' pro- 
gram and did not depend on the LF concentration i  the 50-500 ng/ 
ml range. Values for N. crassa V-ATPase are taken from [13]. 
potency of the different bafilomycins correlates with their abil- 
ity to inhibit the V-ATPase [12]. Fig. 2 shows that bafA1 and 
concanamycin do not affect either fixation or cell entry of 
[t25I]LF into J774A.1 cells. These experiments identify conc 
A and bafA1 as the two most powerful inhibitors of LF 
macrophage cytotoxicity. Their efficacy and lack of known 
effects on other cellular targets, in the range on concentrations 
used here, suggest hat they will be very useful in studies on 
the molecular mechanism of cell intoxication by LF. 
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Fig. 2. Effect of bafilomycin A1 and concanamycin A on 126I-LF 
binding of to macrophage cells. J774.A1 cells were incubated at 4°C 
without or with concanamycin A (5× 10 s M) or bafilomycin AI 
(5 × 10 -7 M) in the absence or presence of PA (500 ng/ml) followed 
by a 1 h incubation with [125I]LF (50 ng/ml). Bound [125I]LF was 
either stripped from the cell surface with pronase, or internalized by 
incubation at 37°C. Black and dark gray bars represent cell bound 
[125I]LF in the absence and presence of PA, respectively. Light gray 
and empty bars represent cell internalized [125I]LF in the absence 
and presence of PA, respectively. Data are average of three indepen- 
dent experiments and bars give SD values. 









• -I 20.  
O- 




• ~ 60  
~ 40 .  




0 30 60 90 120 
t ime (min)  
Fig. 3. Effect of bafllomycin A1 and bafilomycin A1 plus monensin 
on neutral red uptake (A) and LF cytotoxycity (B) of macrophage 
cells. (A) J774.A1 cells were incubated for the time periods indicated 
in abscissa with bafilomycin A1 (5x 10 -7 M) (~)  or bafilomycin 
A1 (5x 10 -7 M) plus monensin (10 ~ M) (e) and then neutral red 
uptake was measured, as described in Section 2. Data are expressed 
as percentage of the dye uptake in untreated cells. Values are the 
mean of five experiments run in triplicate and bars represent SE. 
(B) J774.A1 cells were incubated with LF and PA (500 ng/ml each) 
at 37°C at time 0. After the time periods indicated on the abscissa, 
bafilomycin AI (5x 10 -7 M) (<>) or bafilomycin A1 (5x 10 -7 M) 
plus monensin (10 -~ M) (e) were added and incubations were pro- 
longed for a further 4 h. Cell death was determined and expressed 
as percentage of the cytopathic effect caused by LF in cells not trea- 
ted with inhibitor. Values are the mean of three experiments run in 
triplicate and bars represent SE. 
following a pathway of receptor-mediated ndocytosis into 
compartments  endowed with a V-ATPase proton pump. Clath- 
r in-coated vesicles, early and late endosomes and lysosomes 
contain the V-ATPase [25]. Panels A of Figs. 3 and 4 show 
that conc A and bafA1 prevent the acidification of intracel- 
lular acidic compartments hat become unable to take up the 
membrane permeant weak base Neutral  red. The kinetic ana- 
lysis of Fig. 3A shows that, within 15 min in the presence of 
bafA1, J774.A1 cells no longer possess t ransmembrane pH 
gradients. Monensin  quenches t ransmembrane pH gradients 
by altering the membrane permeabil ity barrier to protons 
[26] and is used here to accelerate the action of bafi lomycin 
A1. In the presence of both monensin and bafi lomycin A1, the 
time required to quench t ransmembrane pH gradients is re- 
duced to less than 10 min. Such a rapid action of these drugs 
allows one to obtain information on when LF enters the acid 
intracellular compartment,  after its cell surface binding. In 
fact, these drugs will prevent LF  cytotoxicity as long as LF 
has not entered the intracellular acidic compartment  where it 
undergoes the low pH-driven structural change that enables it 
to translocate into the cytosol, where its exerts its toxic activ- 
ity [22]. Panels B of Figs. 3 and 4 show that drugs that pre- 
vent acidification of intracellular acidic compartments also 
prevent LF  intoxication of J774.A1 cells long after LF addi- 
t ion to cells. Under  the conditions of most rapid quenching of 
intracellular acidic pH, i.e. bafilomycin A1 plus monensin, 
cells are protected for more than 1 h. Cell ligands such as 
EGF  or LDL  enter early endosomal compartments within 
few minutes and move to late endosomal compartments with- 
in 20-30 min [27,28]. Based on these data, the present results 
indicate that LF undergoes the low pH-dependent step of its 
cell intoxication process in late endosomal compartments.  
This work does not shed light on the intracellular compart-  
ment from which LF escapes into the cytosol. But it indicates 
that the acidic organelle where LF becomes competent o 
cross the membrane is a late endosomal compartment.  The 
actual translocation of LF  into the cytosol could take place in 
late endosomes themselves as well as in the trans Golgi com- 
partment  which is dynamically linked to late endosomes via a 
membrane trafficking pathway controlled by rab9 [29,30]. 
This is at variance from what was found before with diphthe- 
ria toxin, which is the best characterized protein toxin requir- 
ing a t ransmembrane pH gradient to translocate its catalytic 
subunit into the cell cytosol. Membrane translocation of 
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Fig. 4. Effect of concanamycin A on the cell accumulation of Neu- 
tral red (A) and on prevention of LF cytotoxycity (B). (A) J774.AI 
cells were incubated for the time periods indicated on the abscissa 
with concanamycin A (5×10 -s M) and Neutral red uptake was 
measured as described in Section 2. Data are expressed as percen- 
tage of the dye uptake in untreated cells. Values are the mean of 
five experiments run in triplicate and bars represent SE. (B) J774.A1 
cells were incubated with LF and PA (500 ng/ml each) at 37°C at 
time 0. After the time periods indicated on the abscissa, concanamy- 
cin A (5 × 10 .8 M) was added and incubations were prolonged for 
a further 4 h. Cell death was determined and expressed as percen- 
tage of the cytopathic effect caused by LF in cells not treated with 
inhibitor. Values are the mean of three experiments run in triplicate 
and bars represent SE. 
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diphtheria toxin takes place within 10 min after the onset of 
endocytosis and is prevented by bafA1 only for few minutes 
after toxin internalization [16,17]. Confocal and electron mi- 
croscopy studies are required to investigate the exact pathway 
followed by LF to entry into cells. Present results indicate that 
LF shares with diphtheria toxin the initial steps of binding 
and endocytosis into early endosomes, but differ afterwards. 
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